{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,22]],"date-time":"2026-06-22T20:13:29Z","timestamp":1782159209089,"version":"3.54.5"},"reference-count":144,"publisher":"AIP Publishing","issue":"4","license":[{"start":{"date-parts":[[2025,12,16]],"date-time":"2025-12-16T00:00:00Z","timestamp":1765843200000},"content-version":"vor","delay-in-days":15,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["pubs.aip.org"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2025,12,1]]},"abstract":"<jats:p>Lung cancer remains the leading cause of cancer-related mortality worldwide, with non-small cell lung cancer accounting for a majority of cases. Despite advances in targeted therapies and immunotherapy, challenges such as tumor heterogeneity, resistance mechanisms, and limited preclinical models hinder treatment efficacy. Traditional cancer models, including 2D cell cultures and animal models, often fail to accurately replicate the lung's complex architecture, microenvironment, and biomechanical cues, leading to poor predictive performance in drug development. Microfluidic-based organ-on-a-chip technology offers a promising alternative by integrating human-derived cells with precisely controlled perfusion, mechanical cues, and tumor\u2013stroma interactions in physiologically relevant 3D models. These platforms enable the study of lung cancer biology, drug responses, and patient-specific therapeutic outcomes with improved accuracy. In this review, we discuss recent advancements in microfluidic systems for recapitulating normal lung physiology and 3D lung cancer microenvironment, covering various microfluidic platforms with applications in disease modeling and drug testing. Unlike other review articles, we bring first-hand insights from clinicians about the current treatment practice for lung cancer and the clinical utilities of lung cancer-on-a-chip models, which bioengineers have been seeking. We also highlight the translational potential of these systems in personalized oncology and the need for interdisciplinary collaborations, particularly with clinicians, to enhance their clinical impact.<\/jats:p>","DOI":"10.1063\/5.0282002","type":"journal-article","created":{"date-parts":[[2025,12,16]],"date-time":"2025-12-16T13:52:36Z","timestamp":1765893156000},"update-policy":"https:\/\/doi.org\/10.1063\/aip-crossmark-policy-page","source":"Crossref","is-referenced-by-count":2,"title":["Microfluidic lung cancer models: Bridging clinical treatment strategies and tumor microenvironment recapitulation"],"prefix":"10.1063","volume":"9","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-6568-9978","authenticated-orcid":false,"given":"Zhiyun","family":"Yu","sequence":"first","affiliation":[{"name":"Department of Cardiovascular and Thoracic Surgery, Rush University Medical Center 1 , 1725 W Harrison Street, Chicago, Illinois 60612,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arsalan A.","family":"Khan","sequence":"additional","affiliation":[{"name":"Department of Cardiovascular and Thoracic Surgery, Rush University Medical Center 1 , 1725 W Harrison Street, Chicago, Illinois 60612,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0000-6718-1318","authenticated-orcid":false,"given":"Wara","family":"Naeem","sequence":"additional","affiliation":[{"name":"Department of Cardiovascular and Thoracic Surgery, Rush University Medical Center 1 , 1725 W Harrison Street, Chicago, Illinois 60612,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1520-7966","authenticated-orcid":false,"given":"Jeffrey A.","family":"Borgia","sequence":"additional","affiliation":[{"name":"Department of Anatomy and Cell Biology, Rush University Medical Center 2 , 1735 W Harrison St, Chicago, Illinois 60612,","place":["USA"]},{"name":"Department of Pathology, Rush University Medical Center 3 , 1750 W Harrison St, Chicago, Illinois 60612,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0006-1906-5877","authenticated-orcid":false,"given":"Michael J.","family":"Liptay","sequence":"additional","affiliation":[{"name":"Department of Cardiovascular and Thoracic Surgery, Rush University Medical Center 1 , 1725 W Harrison Street, Chicago, Illinois 60612,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4070-1245","authenticated-orcid":false,"given":"Christopher W.","family":"Seder","sequence":"additional","affiliation":[{"name":"Department of Cardiovascular and Thoracic Surgery, Rush University Medical Center 1 , 1725 W Harrison Street, Chicago, Illinois 60612,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8676-8891","authenticated-orcid":false,"given":"Jian","family":"Zhou","sequence":"additional","affiliation":[{"name":"Department of Cardiovascular and Thoracic Surgery, Rush University Medical Center 1 , 1725 W Harrison Street, Chicago, Illinois 60612,","place":["USA"]},{"name":"Department of Anatomy and Cell Biology, Rush University Medical Center 2 , 1735 W Harrison St, Chicago, Illinois 60612,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"317","published-online":{"date-parts":[[2025,12,16]]},"reference":[{"issue":"3","key":"2025121608523163100_c1","doi-asserted-by":"publisher","first-page":"209","DOI":"10.3322\/caac.21660","article-title":"Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries","volume":"71","year":"2021","journal-title":"CA Cancer J. Clin."},{"issue":"3","key":"2025121608523163100_c2","doi-asserted-by":"publisher","first-page":"229","DOI":"10.3322\/caac.21834","article-title":"Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries","volume":"74","year":"2024","journal-title":"CA Cancer J. Clin."},{"issue":"7689","key":"2025121608523163100_c3","doi-asserted-by":"publisher","first-page":"446","DOI":"10.1038\/nature25183","article-title":"The biology and management of non-small cell lung cancer","volume":"553","year":"2018","journal-title":"Nature"},{"issue":"9","key":"2025121608523163100_c4","doi-asserted-by":"publisher","first-page":"660","DOI":"10.3390\/diagnostics10090660","article-title":"Spontaneous and induced animal models for cancer research","volume":"10","year":"2020","journal-title":"Diagnostics"},{"issue":"6378","key":"2025121608523163100_c5","doi-asserted-by":"publisher","first-page":"920","DOI":"10.1126\/science.aao2774","article-title":"Patient-derived organoids model treatment response of metastatic gastrointestinal cancers","volume":"359","year":"2018","journal-title":"Science"},{"issue":"6444","key":"2025121608523163100_c6","doi-asserted-by":"publisher","first-page":"960","DOI":"10.1126\/science.aaw7894","article-title":"Organoids-on-a-chip","volume":"364","year":"2019","journal-title":"Science"},{"issue":"1","key":"2025121608523163100_c7","doi-asserted-by":"publisher","first-page":"30","DOI":"10.15283\/ijsc23090","article-title":"Lung organoid on a chip: A new ensemble model for preclinical studies","volume":"17","year":"2024","journal-title":"Int. J. Stem Cells"},{"key":"2025121608523163100_c8","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1515\/mr-2023-0047","article-title":"Organoids as preclinical models of human disease: Progress and applications","volume":"4","year":"2024","journal-title":"Med. Rev."},{"key":"2025121608523163100_c9","doi-asserted-by":"publisher","first-page":"100742","DOI":"10.1016\/j.ctarc.2023.100742","article-title":"Real-world study of disease-free survival and patient characteristics associated with disease-free survival in early-stage non-small cell lung cancer: A retrospective observational study","volume":"36","year":"2023","journal-title":"Cancer Treat. Res. Commun."},{"issue":"1","key":"2025121608523163100_c10","doi-asserted-by":"publisher","first-page":"17","DOI":"10.3322\/caac.21763","article-title":"Cancer statistics, 2023","volume":"73","year":"2023","journal-title":"CA Cancer J. Clin."},{"key":"2025121608523163100_c11","doi-asserted-by":"publisher","first-page":"1260","DOI":"10.1016\/j.chest.2023.11.042","article-title":"Recurrence-free survival in patients with surgically resected non-small cell lung cancer: A systematic literature review and meta-analysis","volume":"165","year":"2024","journal-title":"Chest"},{"issue":"2","key":"2025121608523163100_c12","doi-asserted-by":"publisher","first-page":"409","DOI":"10.1016\/j.athoracsur.2006.08.046","article-title":"Survival after recurrent nonsmall-cell lung cancer after complete pulmonary resection","volume":"83","year":"2007","journal-title":"Ann. Thorac. Surg."},{"key":"2025121608523163100_c13","doi-asserted-by":"publisher","first-page":"734","DOI":"10.1016\/j.athoracsur.2023.12.011","article-title":"Long-term survival after lung cancer resection in the national lung screening trial","volume":"117","year":"2024","journal-title":"Ann. Thorac. Surg."},{"issue":"1","key":"2025121608523163100_c14","doi-asserted-by":"publisher","first-page":"506","DOI":"10.21037\/tlcr.2020.03.40","article-title":"Epidemiology of stage III lung cancer: Frequency, diagnostic characteristics, and survival","volume":"10","year":"2021","journal-title":"Transl. Lung Cancer Res."},{"key":"2025121608523163100_c15","doi-asserted-by":"publisher","first-page":"100727","DOI":"10.1016\/j.ctarc.2023.100727","article-title":"Treatment of unresectable stage III NSCLC: Real world cohort study and literature review","volume":"36","year":"2023","journal-title":"Cancer Treat. Res. Commun."},{"key":"2025121608523163100_c16","doi-asserted-by":"publisher","first-page":"120","DOI":"10.1016\/S0022-5223(95)70427-2","article-title":"Incidence of local recurrence and second primary tumors in resected stage I lung cancer","volume":"109","year":"1995","journal-title":"J. Thorac. Cardiovasc. Surg."},{"issue":"4","key":"2025121608523163100_c17","doi-asserted-by":"publisher","first-page":"351","DOI":"10.1056\/NEJMoa031644","article-title":"Cisplatin-based adjuvant chemotherapy in patients with completely resected non-small-cell lung cancer","volume":"350","author":"The Writing Committee for the International Adjuvant Lung Cancer Trial (IALT)","year":"2004","journal-title":"N. Engl. J. Med."},{"issue":"21","key":"2025121608523163100_c18","doi-asserted-by":"publisher","first-page":"3552","DOI":"10.1200\/JCO.2007.13.9030","article-title":"Lung adjuvant cisplatin evaluation: A pooled analysis by the LACE collaborative group","volume":"26","year":"2008","journal-title":"J. Clin. Oncol."},{"issue":"5","key":"2025121608523163100_c19","doi-asserted-by":"publisher","first-page":"717","DOI":"10.1001\/jamaoncol.2022.0039","article-title":"Rates of guideline-concordant surgery and adjuvant chemotherapy among patients with early-stage lung cancer in the US ALCHEMIST study (Alliance A151216)","volume":"8","year":"2022","journal-title":"JAMA Oncol."},{"issue":"2","key":"2025121608523163100_c20","doi-asserted-by":"publisher","first-page":"411","DOI":"10.1016\/j.jtcvs.2024.01.048","article-title":"Induction therapy for non-small cell lung cancer","volume":"168","year":"2024","journal-title":"J. Thorac. Cardiovasc. Surg."},{"issue":"21","key":"2025121608523163100_c21","doi-asserted-by":"publisher","first-page":"1973","DOI":"10.1056\/NEJMoa2202170","article-title":"Neoadjuvant nivolumab plus chemotherapy in resectable lung cancer","volume":"386","year":"2022","journal-title":"N. Engl. J. Med."},{"issue":"6","key":"2025121608523163100_c22","doi-asserted-by":"publisher","first-page":"491","DOI":"10.1056\/NEJMoa2302983","article-title":"Perioperative pembrolizumab for early-stage non-small-cell lung cancer","volume":"389","year":"2023","journal-title":"N. Engl. J. Med."},{"key":"2025121608523163100_c23","doi-asserted-by":"publisher","first-page":"S1295","DOI":"10.1016\/j.annonc.2023.10.050","article-title":"LBA1 CheckMate 77T: Phase III study comparing neoadjuvant nivolumab (NIVO) plus chemotherapy (chemo) vs neoadjuvant placebo plus chemo followed by surgery and adjuvant NIVO or placebo for previously untreated, resectable stage II\u2013IIIb NSCLC","volume":"34","year":"2023","journal-title":"Ann. Oncol."},{"issue":"10308","key":"2025121608523163100_c24","doi-asserted-by":"publisher","first-page":"1344","DOI":"10.1016\/S0140-6736(21)02098-5","article-title":"Adjuvant atezolizumab after adjuvant chemotherapy in resected stage IB\u2013IIIA non-small-cell lung cancer (IMpower010): A randomised, multicentre, open-label, phase 3 trial","volume":"398","year":"2021","journal-title":"Lancet"},{"issue":"10","key":"2025121608523163100_c25","doi-asserted-by":"publisher","first-page":"1274","DOI":"10.1016\/S1470-2045(22)00518-6","article-title":"Pembrolizumab versus placebo as adjuvant therapy for completely resected stage IB\u2013IIIA non-small-cell lung cancer (PEARLS\/KEYNOTE-091): An interim analysis of a randomised, triple-blind, phase 3 trial","volume":"23","year":"2022","journal-title":"Lancet Oncol."},{"issue":"18","key":"2025121608523163100_c26","doi-asserted-by":"publisher","first-page":"1711","DOI":"10.1056\/NEJMoa2027071","article-title":"Osimertinib in resected EGFR-mutated non-small-cell lung cancer","volume":"383","year":"2020","journal-title":"N. Engl. J. Med."},{"issue":"2","key":"2025121608523163100_c27","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1056\/NEJMoa2304594","article-title":"Overall survival with osimertinib in resected EGFR-mutated NSCLC","volume":"389","year":"2023","journal-title":"N. Engl. J. Med."},{"issue":"31","key":"2025121608523163100_c28","doi-asserted-by":"publisher","first-page":"4045","DOI":"10.2217\/fon-2021-0549","article-title":"Neoadjuvant osimertinib with\/without chemotherapy versus chemotherapy alone for EGFR-mutated resectable non-small-cell lung cancer: NeoADAURA","volume":"17","year":"2021","journal-title":"Future Oncol."},{"issue":"5","key":"2025121608523163100_c29","doi-asserted-by":"publisher","first-page":"473","DOI":"10.1016\/j.cllc.2021.02.014","article-title":"Phase II, open-label, single-arm, multicenter study to assess the activity and safety of alectinib as neoadjuvant treatment in surgically resectable stage III ALK-positive NSCLC: ALNEO trial","volume":"22","year":"2021","journal-title":"Clin. Lung Cancer"},{"issue":"1","key":"2025121608523163100_c30","doi-asserted-by":"publisher","first-page":"162","DOI":"10.1186\/s12935-023-02990-y","article-title":"Recent advances in non-small cell lung cancer targeted therapy; an update review","volume":"23","year":"2023","journal-title":"Cancer Cell Int."},{"issue":"9","key":"2025121608523163100_c31","doi-asserted-by":"publisher","first-page":"2394","DOI":"10.3390\/cancers12092394","article-title":"Targeting HER3, a catalytically defective receptor tyrosine kinase, prevents resistance of lung cancer to a third-generation EGFR kinase inhibitor","volume":"12","year":"2020","journal-title":"Cancers"},{"key":"2025121608523163100_c32","doi-asserted-by":"publisher","first-page":"115891","DOI":"10.1016\/j.biopha.2023.115891","article-title":"Advances and challenges in the treatment of lung cancer","volume":"169","year":"2023","journal-title":"Biomed. Pharmacother."},{"issue":"9","key":"2025121608523163100_c33","doi-asserted-by":"publisher","first-page":"2307","DOI":"10.1002\/anie.201710398","article-title":"Lessons to be learned: The molecular basis of kinase-targeted therapies and drug resistance in non-small cell lung cancer","volume":"57","year":"2018","journal-title":"Angew. Chem., Int. Ed."},{"issue":"3","key":"2025121608523163100_c34","doi-asserted-by":"publisher","first-page":"330","DOI":"10.1038\/s43018-023-00515-0","article-title":"ALK-positive lung cancer: A moving target","volume":"4","year":"2023","journal-title":"Nat. Cancer"},{"issue":"7101","key":"2025121608523163100_c35","doi-asserted-by":"publisher","first-page":"368","DOI":"10.1038\/nature05058","article-title":"The origins and the future of microfluidics","volume":"442","year":"2006","journal-title":"Nature"},{"issue":"3","key":"2025121608523163100_c36","doi-asserted-by":"publisher","first-page":"032005","DOI":"10.1088\/2631-7990\/ad2c5f","article-title":"Functional microfluidics: Theory, microfabrication, and applications","volume":"6","year":"2024","journal-title":"Int. J. Extreme Manuf."},{"issue":"6","key":"2025121608523163100_c37","doi-asserted-by":"publisher","first-page":"3231","DOI":"10.1021\/acsbiomaterials.9b01667","article-title":"Microphysiological systems: Design, fabrication, and applications","volume":"6","year":"2020","journal-title":"ACS Biomater. Sci. Eng."},{"issue":"7","key":"2025121608523163100_c38","doi-asserted-by":"publisher","first-page":"E211","DOI":"10.1111\/aor.14232","article-title":"Advances in microfabrication technologies in tissue engineering and regenerative medicine","volume":"46","year":"2022","journal-title":"Artif. Organs"},{"issue":"1","key":"2025121608523163100_c39","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1016\/j.nantod.2009.12.001","article-title":"Microfluidic tools for cell biological research","volume":"5","year":"2010","journal-title":"Nano Today"},{"issue":"1","key":"2025121608523163100_c40","doi-asserted-by":"publisher","first-page":"2","DOI":"10.3390\/jfb13010002","article-title":"Properties and applications of PDMS for biomedical engineering: A review","volume":"13","year":"2021","journal-title":"J. Funct. Biomater."},{"issue":"1","key":"2025121608523163100_c41","doi-asserted-by":"publisher","first-page":"76","DOI":"10.1038\/s41378-020-00185-3","article-title":"Microtechnology-based methods for organoid models","volume":"6","year":"2020","journal-title":"Microsyst. Nanoeng."},{"issue":"4","key":"2025121608523163100_c42","doi-asserted-by":"publisher","first-page":"427","DOI":"10.1007\/s42242-020-00093-5","article-title":"Generation of microfluidic gradients and their effects on cells behaviours","volume":"3","year":"2020","journal-title":"Biodes. Manuf."},{"issue":"5","key":"2025121608523163100_c43","doi-asserted-by":"publisher","first-page":"859","DOI":"10.1016\/j.immuni.2021.01.012","article-title":"Chemokines and the immune response to cancer","volume":"54","year":"2021","journal-title":"Immunity"},{"issue":"18","key":"2025121608523163100_c44","doi-asserted-by":"publisher","first-page":"3394","DOI":"10.1039\/C6LC00772D","article-title":"Implementing oxygen control in chip-based cell and tissue culture systems","volume":"16","year":"2016","journal-title":"Lab Chip"},{"key":"2025121608523163100_c45","doi-asserted-by":"publisher","first-page":"3906","DOI":"10.1039\/D3LC00531C","article-title":"Bridging the gap between tumor-on-chip and clinics: A systematic review of 15 years of studies","volume":"23","year":"2023","journal-title":"Lab Chip"},{"issue":"22","key":"2025121608523163100_c46","doi-asserted-by":"publisher","first-page":"4305","DOI":"10.1039\/C4LC00853G","article-title":"Oxygen control with microfluidics","volume":"14","year":"2014","journal-title":"Lab Chip"},{"key":"2025121608523163100_c47","doi-asserted-by":"publisher","first-page":"508","DOI":"10.1016\/j.celrep.2017.09.043","article-title":"Human organ chip models recapitulate orthotopic lung cancer growth, therapeutic responses, and tumor dormancy in vitro","volume":"21","year":"2017","journal-title":"Cell Rep."},{"key":"2025121608523163100_c48","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1038\/s41568-018-0104-6","article-title":"Modelling cancer in microfluidic human organs-on-chips","volume":"19","year":"2019","journal-title":"Nat. Rev. Cancer"},{"issue":"48","key":"2025121608523163100_c49","doi-asserted-by":"publisher","first-page":"18886","DOI":"10.1073\/pnas.0610868104","article-title":"Acoustically detectable cellular-level lung injury induced by fluid mechanical stresses in microfluidic airway systems","volume":"104","year":"2007","journal-title":"Proc. Natl. Acad. Sci."},{"key":"2025121608523163100_c50","doi-asserted-by":"publisher","first-page":"2953","DOI":"10.1111\/all.16179","article-title":"Comprehensive analysis of resilience of human airway epithelial barrier against short-term PM2.5 inorganic dust exposure using in vitro microfluidic chip and ex vivo human airway models","volume":"79","year":"2024","journal-title":"Allergy"},{"issue":"5986","key":"2025121608523163100_c51","doi-asserted-by":"publisher","first-page":"1662","DOI":"10.1126\/science.1188302","article-title":"Reconstituting organ-level lung functions on a chip","volume":"328","year":"2010","journal-title":"Science"},{"issue":"12","key":"2025121608523163100_c52","doi-asserted-by":"publisher","first-page":"2071","DOI":"10.1039\/C9LC00148D","article-title":"Engineering tumor vasculature on an injection-molded plastic array 3D culture (IMPACT) platform","volume":"19","year":"2019","journal-title":"Lab Chip"},{"key":"2025121608523163100_c53","doi-asserted-by":"publisher","first-page":"6","DOI":"10.3389\/fphar.2018.00006","article-title":"Three-dimensional in vitro cell culture models in drug discovery and drug repositioning","volume":"9","year":"2018","journal-title":"Front. Pharmacol."},{"issue":"5","key":"2025121608523163100_c54","doi-asserted-by":"publisher","first-page":"405","DOI":"10.1038\/nmeth.3839","article-title":"A practical guide to hydrogels for cell culture","volume":"13","year":"2016","journal-title":"Nat. Methods"},{"key":"2025121608523163100_c55","doi-asserted-by":"publisher","first-page":"2025","DOI":"10.1039\/D3LC01044A","article-title":"Deciphering fibroblast-induced drug resistance in non-small cell lung carcinoma through patient-derived organoids in agarose microwells","volume":"24","year":"2024","journal-title":"Lab Chip"},{"issue":"4","key":"2025121608523163100_c56","doi-asserted-by":"publisher","first-page":"587","DOI":"10.3390\/mi13040587","article-title":"Uniform tumor spheroids on surface-optimized microfluidic biochips for reproducible drug screening and personalized medicine","volume":"13","year":"2022","journal-title":"Micromachines"},{"issue":"17","key":"2025121608523163100_c57","doi-asserted-by":"publisher","first-page":"2854","DOI":"10.1039\/C9LC00496C","article-title":"A one-stop microfluidic-based lung cancer organoid culture platform for testing drug sensitivity","volume":"19","year":"2019","journal-title":"Lab Chip"},{"issue":"11","key":"2025121608523163100_c58","doi-asserted-by":"publisher","first-page":"3041","DOI":"10.1002\/bit.27114","article-title":"In vitro lung cancer multicellular tumor spheroid formation using a microfluidic device","volume":"116","year":"2019","journal-title":"Biotechnol. Bioeng."},{"issue":"16","key":"2025121608523163100_c59","doi-asserted-by":"publisher","first-page":"4109","DOI":"10.1016\/j.biomaterials.2013.02.045","article-title":"Application of a microfluidic chip-based 3D co-culture to test drug sensitivity for individualized treatment of lung cancer","volume":"34","year":"2013","journal-title":"Biomaterials"},{"key":"2025121608523163100_c60","doi-asserted-by":"publisher","first-page":"126298","DOI":"10.1016\/j.talanta.2024.126298","article-title":"A versatile dilution-treatment-detection microfluidic chip platform for rapid In vitro lung cancer drug combination sensitivity evaluation","volume":"277","year":"2024","journal-title":"Talanta"},{"issue":"32","key":"2025121608523163100_c61","doi-asserted-by":"publisher","first-page":"13061","DOI":"10.1021\/acs.analchem.4c01389","article-title":"Quantitatively evaluating interactions between patient-derived organoids and autologous immune cells by microfluidic chip","volume":"96","year":"2024","journal-title":"Anal. Chem."},{"key":"2025121608523163100_c62","doi-asserted-by":"publisher","first-page":"17027","DOI":"10.1021\/acs.analchem.4c05111","article-title":"Microfluidic chip-based automatic system for sequencing patient-derived organoids at the single-cell level","volume":"96","year":"2024","journal-title":"Anal. Chem."},{"issue":"1","key":"2025121608523163100_c63","doi-asserted-by":"publisher","first-page":"115","DOI":"10.3390\/biom14010115","article-title":"Alveolar organoids in lung disease modeling","volume":"14","year":"2024","journal-title":"Biomolecules"},{"issue":"1","key":"2025121608523163100_c64","doi-asserted-by":"publisher","first-page":"112","DOI":"10.1016\/j.devcel.2021.11.007","article-title":"A census of the lung: CellCards from LungMAP","volume":"57","year":"2022","journal-title":"Dev. Cell"},{"issue":"7831","key":"2025121608523163100_c65","doi-asserted-by":"publisher","first-page":"785","DOI":"10.1038\/s41586-020-2822-7","article-title":"Capillary cell-type specialization in the alveolus","volume":"586","year":"2020","journal-title":"Nature"},{"key":"2025121608523163100_c66","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1016\/j.canlet.2020.01.030","article-title":"Organoid models in lung regeneration and cancer","volume":"475","year":"2020","journal-title":"Cancer Lett."},{"issue":"47","key":"2025121608523163100_c67","doi-asserted-by":"publisher","first-page":"5771","DOI":"10.1038\/onc.2015.85","article-title":"Lineage factors and differentiation states in lung cancer progression","volume":"34","year":"2015","journal-title":"Oncogene"},{"issue":"2","key":"2025121608523163100_c68","doi-asserted-by":"publisher","first-page":"126","DOI":"10.1038\/ncb2657","article-title":"Tracing the cellular origin of cancer","volume":"15","year":"2013","journal-title":"Nat. Cell Biol."},{"issue":"6","key":"2025121608523163100_c69","doi-asserted-by":"publisher","first-page":"754","DOI":"10.1016\/j.ccr.2011.04.019","article-title":"Cell of origin of small cell lung cancer: Inactivation of Trp53 and Rb1 in distinct cell types of adult mouse lung","volume":"19","year":"2011","journal-title":"Cancer Cell"},{"issue":"4","key":"2025121608523163100_c70","doi-asserted-by":"publisher","first-page":"519","DOI":"10.1016\/j.ccell.2016.09.001","article-title":"SOX2 is the determining oncogenic switch in promoting lung squamous cell carcinoma from different cells of origin","volume":"30","year":"2016","journal-title":"Cancer Cell"},{"issue":"7491","key":"2025121608523163100_c71","doi-asserted-by":"publisher","first-page":"190","DOI":"10.1038\/nature12930","article-title":"Alveolar progenitor and stem cells in lung development, renewal and cancer","volume":"507","year":"2014","journal-title":"Nature"},{"issue":"2","key":"2025121608523163100_c72","doi-asserted-by":"publisher","first-page":"308","DOI":"10.1158\/2159-8290.CD-23-0289","article-title":"Alveolar differentiation drives resistance to KRAS inhibition in lung adenocarcinoma","volume":"14","year":"2024","journal-title":"Cancer Discovery"},{"issue":"1","key":"2025121608523163100_c73","doi-asserted-by":"publisher","first-page":"e0227174","DOI":"10.1371\/journal.pone.0227174","article-title":"Human lung epithelial BEAS-2B cells exhibit characteristics of mesenchymal stem cells","volume":"15","year":"2020","journal-title":"PLoS One"},{"issue":"11","key":"2025121608523163100_c74","doi-asserted-by":"publisher","first-page":"e15700","DOI":"10.14814\/phy2.15700","article-title":"Cellular heterogeneity in the 16HBE14o\u2212 airway epithelial line impacts biological readouts","volume":"11","year":"2023","journal-title":"Physiol. Rep."},{"issue":"17","key":"2025121608523163100_c75","doi-asserted-by":"publisher","first-page":"3349","DOI":"10.1039\/C4LC00552J","article-title":"A biomimetic multicellular model of the airways using primary human cells","volume":"14","year":"2014","journal-title":"Lab Chip"},{"issue":"1","key":"2025121608523163100_c76","doi-asserted-by":"publisher","first-page":"14359","DOI":"10.1038\/s41598-018-32523-x","article-title":"Medium throughput breathing human primary cell alveolus-on-chip model","volume":"8","year":"2018","journal-title":"Sci. Rep."},{"issue":"1","key":"2025121608523163100_c77","doi-asserted-by":"publisher","first-page":"168","DOI":"10.1038\/s42003-021-01695-0","article-title":"Second-generation lung-on-a-chip with an array of stretchable alveoli made with a biological membrane","volume":"4","year":"2021","journal-title":"Commun. Biol."},{"issue":"9","key":"2025121608523163100_c78","doi-asserted-by":"publisher","first-page":"1298","DOI":"10.1039\/C7LC01357D","article-title":"Microfluidic lung airway-on-a-chip with arrayable suspended gels for studying epithelial and smooth muscle cell interactions","volume":"18","year":"2018","journal-title":"Lab Chip"},{"issue":"2","key":"2025121608523163100_c79","doi-asserted-by":"publisher","first-page":"332","DOI":"10.1002\/cpt.742","article-title":"A primary human lung alveolus-on-a-chip model of intravascular thrombosis for assessment of therapeutics","volume":"103","year":"2018","journal-title":"Clin. Pharmacol. Ther."},{"issue":"2","key":"2025121608523163100_c80","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1038\/nmeth.3697","article-title":"Small airway-on-a-chip enables analysis of human lung inflammation and drug responses in vitro","volume":"13","year":"2016","journal-title":"Nat. Methods"},{"issue":"1","key":"2025121608523163100_c81","doi-asserted-by":"publisher","first-page":"17","DOI":"10.7150\/ijbs.105702","article-title":"Advanced lung-on-a-chip technology: Mimicking the complex human lung microenvironment","volume":"21","year":"2025","journal-title":"Int. J. Biol. Sci."},{"issue":"6","key":"2025121608523163100_c82","doi-asserted-by":"publisher","first-page":"1794","DOI":"10.1039\/D3LC00894K","article-title":"Gravity-perfused airway-on-a-chip optimized for quantitative BSL-3 studies of SARS-CoV-2 infection: Barrier permeability, cytokine production, immunohistochemistry, and viral load assays","volume":"24","year":"2024","journal-title":"Lab Chip"},{"issue":"1","key":"2025121608523163100_c83","doi-asserted-by":"publisher","first-page":"168","DOI":"10.1038\/s41392-022-01024-9","article-title":"Human organoids in basic research and clinical applications","volume":"7","year":"2022","journal-title":"Signal Transduction Targeted Ther."},{"key":"2025121608523163100_c84","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1016\/B978-0-12-416022-4.00008-1","article-title":"Lung stem and progenitor cells in tissue homeostasis and disease","volume":"107","year":"2014","journal-title":"Curr. Top. Dev. Biol."},{"issue":"1","key":"2025121608523163100_c85","doi-asserted-by":"publisher","first-page":"875","DOI":"10.1038\/s42003-022-03828-5","article-title":"Human alveolar progenitors generate dual lineage bronchioalveolar organoids","volume":"5","year":"2022","journal-title":"Commun. Biol."},{"issue":"4","key":"2025121608523163100_c86","doi-asserted-by":"publisher","first-page":"482","DOI":"10.1016\/j.stem.2020.03.009","article-title":"The cellular and physiological basis for lung repair and regeneration: Past, present, and future","volume":"26","year":"2020","journal-title":"Cell Stem Cell"},{"issue":"5","key":"2025121608523163100_c87","doi-asserted-by":"publisher","first-page":"653","DOI":"10.1007\/s13770-024-00628-2","article-title":"Lung organoids: Systematic review of recent advancements and its future perspectives","volume":"21","year":"2024","journal-title":"Tissue Eng. Regener. Med."},{"issue":"3","key":"2025121608523163100_c88","doi-asserted-by":"publisher","first-page":"394","DOI":"10.1016\/j.stemcr.2014.07.005","article-title":"Generation of alveolar epithelial spheroids via isolated progenitor cells from human pluripotent stem cells","volume":"3","year":"2014","journal-title":"Stem Cell Rep."},{"issue":"4","key":"2025121608523163100_c89","doi-asserted-by":"publisher","first-page":"472","DOI":"10.1016\/j.stem.2017.08.014","article-title":"Differentiation of human pluripotent stem cells into functional lung alveolar epithelial cells","volume":"21","year":"2017","journal-title":"Cell Stem Cell"},{"issue":"1","key":"2025121608523163100_c90","doi-asserted-by":"publisher","first-page":"84","DOI":"10.1038\/nbt.2754","article-title":"Efficient generation of lung and airway epithelial cells from human pluripotent stem cells","volume":"32","year":"2014","journal-title":"Nat. Biotechnol."},{"issue":"6","key":"2025121608523163100_c91","doi-asserted-by":"publisher","first-page":"844","DOI":"10.1016\/j.stem.2017.03.001","article-title":"Efficient derivation of functional human airway epithelium from pluripotent stem cells via temporal regulation of Wnt signaling","volume":"20","year":"2017","journal-title":"Cell Stem Cell"},{"issue":"21","key":"2025121608523163100_c92","doi-asserted-by":"publisher","first-page":"3879","DOI":"10.1242\/dev.150193","article-title":"Pluripotent stem cell differentiation reveals distinct developmental pathways regulating lung-versus thyroid-lineage specification","volume":"144","year":"2017","journal-title":"Development"},{"issue":"6","key":"2025121608523163100_c93","doi-asserted-by":"publisher","first-page":"2277","DOI":"10.1172\/JCI89950","article-title":"Prospective isolation of NKX2-1-expressing human lung progenitors derived from pluripotent stem cells","volume":"127","year":"2017","journal-title":"J. Clin. Invest."},{"issue":"3","key":"2025121608523163100_c94","doi-asserted-by":"publisher","first-page":"431","DOI":"10.1016\/j.stemcr.2019.01.014","article-title":"In vitro disease modeling of Hermansky-Pudlak syndrome type 2 using human induced pluripotent stem cell-derived alveolar organoids","volume":"12","year":"2019","journal-title":"Stem Cell Rep."},{"issue":"8","key":"2025121608523163100_c95","doi-asserted-by":"publisher","first-page":"e1700521","DOI":"10.1126\/sciadv.1700521","article-title":"Functional vascularized lung grafts for lung bioengineering","volume":"3","year":"2017","journal-title":"Sci. Adv."},{"issue":"1","key":"2025121608523163100_c96","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1038\/s41568-018-0081-9","article-title":"The lung microenvironment: An important regulator of tumour growth and metastasis","volume":"19","year":"2019","journal-title":"Nat. Rev. Cancer"},{"issue":"4","key":"2025121608523163100_c97","doi-asserted-by":"publisher","first-page":"233","DOI":"10.1038\/nrc3477","article-title":"Mechanistic links between COPD and lung cancer","volume":"13","year":"2013","journal-title":"Nat. Rev. Cancer"},{"issue":"1","key":"2025121608523163100_c98","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1378\/chest.11-2458","article-title":"Prognostic impact of cancer-associated stromal cells in patients with stage I lung adenocarcinoma","volume":"142","year":"2012","journal-title":"Chest"},{"issue":"8","key":"2025121608523163100_c99","doi-asserted-by":"publisher","first-page":"E833","DOI":"10.21037\/jtd.2016.07.75","article-title":"Tumor infiltrating lymphocytes in lung cancer: A new prognostic parameter","volume":"8","year":"2016","journal-title":"J. Thorac. Dis."},{"issue":"5","key":"2025121608523163100_c100","doi-asserted-by":"publisher","first-page":"585","DOI":"10.1097\/JTO.0b013e3181d60fd7","article-title":"Tumor-infiltrating Foxp3+ regulatory T cells are correlated with cyclooxygenase-2 expression and are associated with recurrence in resected non-small cell lung cancer","volume":"5","year":"2010","journal-title":"J. Thorac. Oncol."},{"issue":"3","key":"2025121608523163100_c101","doi-asserted-by":"publisher","first-page":"242","DOI":"10.1177\/2472555218812429","article-title":"Implementation of the NCI-60 human tumor cell line panel to screen 2260 cancer drug combinations to generate &gt;3 million data points used to populate a large matrix of anti-neoplastic agent combinations (ALMANAC) database","volume":"24","year":"2019","journal-title":"SLAS Discovery"},{"issue":"1","key":"2025121608523163100_c102","doi-asserted-by":"publisher","first-page":"301","DOI":"10.1186\/s12885-019-5527-2","article-title":"Expression of C-terminal ALK, RET, or ROS1 in lung cancer cells with or without fusion","volume":"19","year":"2019","journal-title":"BMC Cancer"},{"issue":"4","key":"2025121608523163100_c103","doi-asserted-by":"publisher","first-page":"874","DOI":"10.3390\/cancers13040874","article-title":"Organoid and spheroid tumor models: Techniques and applications","volume":"13","year":"2021","journal-title":"Cancers"},{"issue":"1","key":"2025121608523163100_c104","doi-asserted-by":"publisher","first-page":"253","DOI":"10.1186\/s13046-019-1257-1","article-title":"Antitumor activity of dual blockade of PD-L1 and MEK in NSCLC patients derived three-dimensional spheroid cultures","volume":"38","year":"2019","journal-title":"J. Exp. Clin. Cancer Res."},{"key":"2025121608523163100_c105","doi-asserted-by":"publisher","first-page":"2041731419889184","DOI":"10.1177\/2041731419889184","article-title":"High-throughput three-dimensional spheroid tumor model using a novel stamp-like tool","volume":"10","year":"2019","journal-title":"J. Tissue Eng."},{"issue":"1","key":"2025121608523163100_c106","doi-asserted-by":"publisher","first-page":"e0169797","DOI":"10.1371\/journal.pone.0169797","article-title":"Microfluidic biopsy trapping device for the real-time monitoring of tumor microenvironment","volume":"12","year":"2017","journal-title":"PLoS One"},{"issue":"3","key":"2025121608523163100_c107","doi-asserted-by":"publisher","first-page":"396","DOI":"10.1016\/j.ccell.2023.12.021","article-title":"Cancer-associated fibroblast phenotypes are associated with patient outcome in non-small cell lung cancer","volume":"42","year":"2024","journal-title":"Cancer Cell"},{"key":"2025121608523163100_c108","doi-asserted-by":"publisher","first-page":"258","DOI":"10.1016\/j.actbio.2022.03.044","article-title":"Microfluidic one-directional interstitial flow generation from cancer to cancer associated fibroblast","volume":"144","year":"2022","journal-title":"Acta Biomater."},{"issue":"2","key":"2025121608523163100_c109","doi-asserted-by":"publisher","first-page":"100553","DOI":"10.1016\/j.xpro.2021.100553","article-title":"Protocol to establish cancer-associated fibroblasts from surgically resected tissues and generate senescent fibroblasts","volume":"2","year":"2021","journal-title":"STAR Protoc."},{"issue":"5","key":"2025121608523163100_c110","doi-asserted-by":"publisher","first-page":"4422","DOI":"10.3390\/ijms24054422","article-title":"Tumor vasculature as an emerging pharmacological target to promote anti-tumor immunity","volume":"24","year":"2023","journal-title":"Int. J. Mol. Sci."},{"issue":"2","key":"2025121608523163100_c111","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1038\/s41419-017-0061-0","article-title":"Defining the role of the tumor vasculature in antitumor immunity and immunotherapy article","volume":"9","year":"2018","journal-title":"Cell Death Dis."},{"issue":"39","key":"2025121608523163100_c112","doi-asserted-by":"publisher","first-page":"25840","DOI":"10.1021\/acsami.6b08746","article-title":"Design and construction of a multi-organ microfluidic chip mimicking the in vivo microenvironment of lung cancer metastasis","volume":"8","year":"2016","journal-title":"ACS Appl. Mater. Interfaces"},{"issue":"16","key":"2025121608523163100_c113","doi-asserted-by":"publisher","first-page":"3930","DOI":"10.3390\/cancers13163930","article-title":"Three-dimensional vascularized lung cancer-on-a-chip with lung extracellular matrix hydrogels for in vitro screening","volume":"13","year":"2021","journal-title":"Cancers"},{"issue":"1","key":"2025121608523163100_c114","doi-asserted-by":"publisher","first-page":"1452","DOI":"10.1038\/s41467-024-45710-4","article-title":"A microfluidic platform integrating functional vascularized organoids-on-chip","volume":"15","year":"2024","journal-title":"Nat. Commun."},{"key":"2025121608523163100_c115","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1007\/s10456-024-09905-z","article-title":"Vascularized organoid-on-a-chip: Design, imaging, and analysis","volume":"27","year":"2024","journal-title":"Angiogenesis"},{"key":"2025121608523163100_c116","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1038\/s41577-023-00896-4","article-title":"Harnessing 3D in vitro systems to model immune responses to solid tumours: A step towards improving and creating personalized immunotherapies","volume":"24","year":"2024","journal-title":"Nat. Rev. Immunol."},{"key":"2025121608523163100_c117","doi-asserted-by":"publisher","first-page":"881207","DOI":"10.3389\/fonc.2022.881207","article-title":"Development of a multicellular 3D tumor model to study cellular heterogeneity and plasticity in NSCLC tumor microenvironment","volume":"12","year":"2022","journal-title":"Front Oncol."},{"issue":"1","key":"2025121608523163100_c118","doi-asserted-by":"publisher","first-page":"3382","DOI":"10.1038\/s41467-024-47737-z","article-title":"A patient-specific lung cancer assembloid model with heterogeneous tumor microenvironments","volume":"15","year":"2024","journal-title":"Nat. Commun."},{"key":"2025121608523163100_c119","doi-asserted-by":"publisher","first-page":"4354","DOI":"10.1021\/acsami.4c09065","article-title":"Investigating T cell immune dynamics and IL-6's duality in a microfluidic lung tumor model","volume":"17","year":"2025","journal-title":"ACS Appl. Mater. Interfaces"},{"issue":"4","key":"2025121608523163100_c120","doi-asserted-by":"publisher","first-page":"877","DOI":"10.21037\/tlcr-22-712","article-title":"Significance of circulating tumor cells in lung cancer: A narrative review","volume":"12","year":"2023","journal-title":"Transl. Lung Cancer Res."},{"issue":"1","key":"2025121608523163100_c121","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1038\/s41378-019-0045-6","article-title":"Isolation of circulating tumor cells in non-small-cell-lung-cancer patients using a multi-flow microfluidic channel","volume":"5","year":"2019","journal-title":"Microsyst. Nanoeng."},{"issue":"6","key":"2025121608523163100_c122","doi-asserted-by":"publisher","first-page":"706","DOI":"10.3390\/mi15060706","article-title":"Novel isolating approaches to circulating tumor cell enrichment based on microfluidics: A review","volume":"15","year":"2024","journal-title":"Micromachines"},{"key":"2025121608523163100_c123","doi-asserted-by":"publisher","first-page":"107522","DOI":"10.1016\/j.pharmthera.2020.107522","article-title":"Acquired resistance to targeted therapies in NSCLC: Updates and evolving insights","volume":"210","year":"2020","journal-title":"Pharmacol. Ther."},{"issue":"1","key":"2025121608523163100_c124","doi-asserted-by":"publisher","first-page":"2301009","DOI":"10.1002\/smtd.202301009","article-title":"Next-generation preclinical functional testing models in cancer precision medicine: CTC-derived organoids","volume":"8","year":"2024","journal-title":"Small Methods"},{"key":"2025121608523163100_c125","doi-asserted-by":"publisher","first-page":"216","DOI":"10.1126\/science.1253533","article-title":"Ex vivo culture of circulating breast tumor cells for individualized testing of drug susceptibility","volume":"345","year":"2014","journal-title":"Science"},{"key":"2025121608523163100_c126","doi-asserted-by":"publisher","first-page":"12383","DOI":"10.18632\/oncotarget.2592","article-title":"Expansion of CTCs from early stage lung cancer patients using a microfluidic co-culture model","volume":"5","year":"2014","journal-title":"Oncotarget"},{"issue":"1","key":"2025121608523163100_c127","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1038\/nprot.2017.125","article-title":"Expansion of patient-derived circulating tumor cells from liquid biopsies using a CTC microfluidic culture device","volume":"13","year":"2018","journal-title":"Nat. Protoc."},{"key":"2025121608523163100_c128","doi-asserted-by":"publisher","first-page":"364","DOI":"10.1016\/j.tcb.2024.10.004","article-title":"The culture and application of circulating tumor cell-derived organoids","volume":"35","year":"2025","journal-title":"Trends Cell Biol."},{"issue":"13","key":"2025121608523163100_c129","doi-asserted-by":"publisher","first-page":"1844","DOI":"10.1039\/C8LC00256H","article-title":"A multiplexed microfluidic system for evaluation of dynamics of immune-tumor interactions","volume":"18","year":"2018","journal-title":"Lab Chip"},{"key":"2025121608523163100_c130","doi-asserted-by":"publisher","first-page":"1133","DOI":"10.3389\/fimmu.2019.01133","article-title":"High-throughput microfluidic 3D cytotoxicity assay for cancer immunotherapy (CACI-ImpacT platform)","volume":"10","year":"2019","journal-title":"Front Immunol."},{"issue":"8","key":"2025121608523163100_c131","doi-asserted-by":"publisher","first-page":"2300077","DOI":"10.1002\/adbi.202300077","article-title":"Microphysiological systems for cancer immunotherapy research and development","volume":"8","year":"2024","journal-title":"Adv. Biol."},{"issue":"7","key":"2025121608523163100_c132","doi-asserted-by":"publisher","first-page":"628","DOI":"10.3390\/mi11070628","article-title":"Analysis of single nucleotide-mutated single-cancer cells using the combined technologies of single-cell microarray chips and peptide nucleic acid-DNA probes","volume":"11","year":"2020","journal-title":"Micromachines"},{"key":"2025121608523163100_c133","doi-asserted-by":"publisher","first-page":"125444","DOI":"10.1016\/j.talanta.2023.125444","article-title":"Detecting EGFR gene amplification using a fluorescence in situ hybridization platform based on digital microfluidics","volume":"269","year":"2024","journal-title":"Talanta"},{"issue":"6","key":"2025121608523163100_c134","doi-asserted-by":"publisher","first-page":"1762","DOI":"10.1039\/D3LC00974B","article-title":"A dual-functional microfluidic chip for guiding personalized lung cancer medicine: Combining EGFR mutation detection and organoid-based drug response test","volume":"24","year":"2024","journal-title":"Lab Chip"},{"issue":"11","key":"2025121608523163100_c135","doi-asserted-by":"publisher","first-page":"3012","DOI":"10.3390\/cells10113012","article-title":"Scientific validation and clinical application of lung cancer organoids","volume":"10","year":"2021","journal-title":"Cells"},{"issue":"1","key":"2025121608523163100_c136","doi-asserted-by":"publisher","first-page":"3991","DOI":"10.1038\/s41467-019-11867-6","article-title":"Patient-derived lung cancer organoids as in vitro cancer models for therapeutic screening","volume":"10","year":"2019","journal-title":"Nat. Commun."},{"issue":"7","key":"2025121608523163100_c137","doi-asserted-by":"publisher","first-page":"712","DOI":"10.3390\/bios13070712","article-title":"Spatial omics sequencing based on microfluidic array chips","volume":"13","year":"2023","journal-title":"Biosensors (Basel)"},{"key":"2025121608523163100_c138","doi-asserted-by":"publisher","first-page":"2259","DOI":"10.1038\/s41588-024-01906-4","article-title":"Custom microfluidic chip design enables cost-effective three-dimensional spatiotemporal transcriptomics with a wide field of view","volume":"56","year":"2024","journal-title":"Nat. Genet."},{"issue":"3","key":"2025121608523163100_c139","doi-asserted-by":"publisher","first-page":"297","DOI":"10.1016\/j.devcel.2018.01.008","article-title":"The strength of mechanical forces determines the differentiation of alveolar epithelial cells","volume":"44","year":"2018","journal-title":"Dev. Cell"},{"issue":"1","key":"2025121608523163100_c140","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1093\/jnci\/djx160","article-title":"Targeting hypoxia to improve non\u2013small cell lung cancer outcome","volume":"110","year":"2018","journal-title":"J. Natl. Cancer Inst."},{"issue":"7","key":"2025121608523163100_c141","doi-asserted-by":"publisher","first-page":"457","DOI":"10.1038\/s41388-023-02929-7","article-title":"Genetically-engineered mouse models of small cell lung cancer: The next generation","volume":"43","year":"2024","journal-title":"Oncogene"},{"issue":"4","key":"2025121608523163100_c142","doi-asserted-by":"publisher","first-page":"663","DOI":"10.1016\/j.stem.2020.07.022","article-title":"Organoids model transcriptional hallmarks of oncogenic KRAS activation in lung epithelial progenitor cells","volume":"27","year":"2020","journal-title":"Cell Stem Cell"},{"issue":"3","key":"2025121608523163100_c143","doi-asserted-by":"publisher","first-page":"470","DOI":"10.1097\/ACM.0b013e3181ccd618","article-title":"Defining translational research: Implications for training","volume":"85","year":"2010","journal-title":"Acad. Med."},{"issue":"4","key":"2025121608523163100_c144","doi-asserted-by":"publisher","first-page":"423","DOI":"10.1242\/dmm.008177","article-title":"The cultural divide: Exploring communication barriers between scientists and clinicians","volume":"4","year":"2011","journal-title":"DMM Dis. Models Mech."}],"container-title":["APL Bioengineering"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/pubs.aip.org\/aip\/apb\/article-pdf\/doi\/10.1063\/5.0282002\/20839691\/041505_1_5.0282002.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/pubs.aip.org\/aip\/apb\/article-pdf\/doi\/10.1063\/5.0282002\/20839691\/041505_1_5.0282002.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,12,16]],"date-time":"2025-12-16T13:52:37Z","timestamp":1765893157000},"score":1,"resource":{"primary":{"URL":"https:\/\/pubs.aip.org\/apb\/article\/9\/4\/041505\/3374913\/Microfluidic-lung-cancer-models-Bridging-clinical"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12,1]]},"references-count":144,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2025,12,1]]}},"URL":"https:\/\/doi.org\/10.1063\/5.0282002","relation":{},"ISSN":["2473-2877"],"issn-type":[{"value":"2473-2877","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2025,12,1]]},"published":{"date-parts":[[2025,12,1]]},"article-number":"041505"}}